Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
In this Consensus Statement, an international group of experts provide updated recommendations on the treatment of acromegaly, including discussion of treatment outcomes.
Vosoritide, a precision pharmacological treatment, was approved for use in patients with achondroplasia in 2021. This Consensus Statement brings together an international group of experts to provide guidelines on the use of vosoritide.
